Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.79 USD | -2.88% |
|
-38.88% | -47.62% |
Jul. 01 | JonesTrading Downgrades Cassava Sciences to Hold From Buy | MT |
Jul. 01 | Cassava Sciences forms internal panel after US probe into two employees | RE |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 18-09-30 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 98-05-31 | |
Robert Cook
LAW | General Counsel | 60 | 22-09-30 |
Michael Marsman
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Robert Gussin
BRD | Director/Board Member | 86 | 03-02-28 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07-12-06 |
Director/Board Member | 92 | 98-08-31 | |
Richard Barry
BRD | Director/Board Member | 65 | 21-06-10 |
Director/Board Member | 65 | 98-05-31 | |
Claude Nicaise
BRD | Director/Board Member | 71 | Dec. 06 |
Robert Anderson
BRD | Director/Board Member | 58 | Dec. 06 |
Pierre Gravier
BRD | Director/Board Member | 39 | Dec. 06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,976,166 | 44,808,216 ( 93.40 %) | 0 | 93.40 % |
Company contact information
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.com![address Cassava Sciences, Inc.(SAVA)](https://cdn.zonebourse.com/static/address/56537199.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.62% | 582M | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- SAVA Stock
- Company Cassava Sciences, Inc.